In vitro and in silico Anti-diabetes mechanism of phytochemicals from Curculigo pilosa and its pharmacokinetic profiling via α-amylase inhibition

Damilola A. Omoboyowa , Temitope C. Aribigbola , Simbo T. Akinsulure , Damilola S. Bodun , Ezekiel A. Olugbogi , Ebenezer A. Oni
{"title":"In vitro and in silico Anti-diabetes mechanism of phytochemicals from Curculigo pilosa and its pharmacokinetic profiling via α-amylase inhibition","authors":"Damilola A. Omoboyowa ,&nbsp;Temitope C. Aribigbola ,&nbsp;Simbo T. Akinsulure ,&nbsp;Damilola S. Bodun ,&nbsp;Ezekiel A. Olugbogi ,&nbsp;Ebenezer A. Oni","doi":"10.1016/j.amolm.2025.100064","DOIUrl":null,"url":null,"abstract":"<div><div>Diabetes mellitus is characterized by elevated blood glucose resulting from carbohydrate metabolism via glucose metabolizing enzymes such as α-amylase. <em>Curculigo pilosa</em> is traditionally used as herbal medication as anti-diabetes therapy but its mechanism of action is yet to be explored. This study investigates α-amylase inhibitory potential of <em>C. pilosa</em> using in vitro and in silico approaches. The ethylacetate, n-butanol and methanol extracts of <em>C. pilosa</em> were subjected to in vitro α-amylase inhibitory assay, followed by identification of the bioactive compounds from the most potent extract using HPLC. Integrated computational analyses were performed on ten (10) active compounds against α-amylase using Maestro Schrodinger (v2). The results of the in vitro α–amylase assay revealed n-butanol extract as the potent extract with IC<sub>50</sub> of 132.70 μg/mL, although the standard drug (acarbose IC<sub>50</sub> = 128.70 μg/mL) inhibits α-amylase better than the extracts. The HPLC result revealed the presence of ten (10) active compounds. Acarbose was observed to possess better binding affinity (−11.502 kcal/mol) than all the compounds but curculigoside was the hit compound with binding affinity of −8.797 kcal/mol. Some of the compounds showed appreciable inhibitory pIC<sub>50</sub> and fitness scores comparable to the standard drug. The pharmacokinetic profile revealed that none of the compounds violated more than one Lipinski's rule of five while the standard drug (acarbose) violated three (3) of the rules. The root mean square deviation shows reasonable level of stability within the simulation period for both curculigoside and acarbose. The result of in silico study showed significant inhibitory potential of the active compounds against α-amylase which was consistent with the in vitro inhibition of α amylase by the plant extract suggesting this as the possible mechanism of antidiabetes action of <em>C. pilosa</em>.</div></div>","PeriodicalId":72320,"journal":{"name":"Aspects of molecular medicine","volume":"5 ","pages":"Article 100064"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aspects of molecular medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949688825000024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetes mellitus is characterized by elevated blood glucose resulting from carbohydrate metabolism via glucose metabolizing enzymes such as α-amylase. Curculigo pilosa is traditionally used as herbal medication as anti-diabetes therapy but its mechanism of action is yet to be explored. This study investigates α-amylase inhibitory potential of C. pilosa using in vitro and in silico approaches. The ethylacetate, n-butanol and methanol extracts of C. pilosa were subjected to in vitro α-amylase inhibitory assay, followed by identification of the bioactive compounds from the most potent extract using HPLC. Integrated computational analyses were performed on ten (10) active compounds against α-amylase using Maestro Schrodinger (v2). The results of the in vitro α–amylase assay revealed n-butanol extract as the potent extract with IC50 of 132.70 μg/mL, although the standard drug (acarbose IC50 = 128.70 μg/mL) inhibits α-amylase better than the extracts. The HPLC result revealed the presence of ten (10) active compounds. Acarbose was observed to possess better binding affinity (−11.502 kcal/mol) than all the compounds but curculigoside was the hit compound with binding affinity of −8.797 kcal/mol. Some of the compounds showed appreciable inhibitory pIC50 and fitness scores comparable to the standard drug. The pharmacokinetic profile revealed that none of the compounds violated more than one Lipinski's rule of five while the standard drug (acarbose) violated three (3) of the rules. The root mean square deviation shows reasonable level of stability within the simulation period for both curculigoside and acarbose. The result of in silico study showed significant inhibitory potential of the active compounds against α-amylase which was consistent with the in vitro inhibition of α amylase by the plant extract suggesting this as the possible mechanism of antidiabetes action of C. pilosa.
莪术植物化学物质体外和体内抗糖尿病机制及α-淀粉酶抑制的药动学分析
糖尿病的特点是通过葡萄糖代谢酶如α-淀粉酶进行碳水化合物代谢导致血糖升高。毛茛是传统的抗糖尿病中药,但其作用机制尚不清楚。本研究采用体外和计算机模拟两种方法研究了毛蕊草α-淀粉酶的抑制潜力。采用乙酸乙酯、正丁醇和甲醇提取物进行体外α-淀粉酶抑制实验,并采用高效液相色谱法对活性最强的提取物进行活性鉴定。采用Maestro Schrodinger (v2)软件对10种α-淀粉酶活性化合物进行了综合计算分析。体外α-淀粉酶活性测定结果显示,正丁醇提取物对α-淀粉酶的抑制作用强于正丁醇提取物,IC50值为132.70 μg/mL,而标准药物(阿卡波糖IC50 = 128.70 μg/mL)对α-淀粉酶的抑制作用优于正丁醇提取物。高效液相色谱分析结果显示含有10种活性化合物。结果表明,阿卡波糖具有较好的结合亲和力(- 11.502 kcal/mol),但莪术苷的结合亲和力为- 8.797 kcal/mol。其中一些化合物显示出明显的抑制pIC50和健康评分,与标准药物相当。药代动力学分析显示,没有一种化合物违反了利平斯基的五定律,而标准药物(阿卡波糖)违反了三(3)条规则。在模拟周期内,曲霉苷和阿卡波糖的均方根偏差均表现出合理的稳定性。硅晶实验结果表明,活性化合物对α-淀粉酶有明显的抑制作用,这与植物提取物对α-淀粉酶的体外抑制作用一致,提示这可能是金针叶抗糖尿病作用的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Aspects of molecular medicine
Aspects of molecular medicine Molecular Biology, Molecular Medicine
自引率
0.00%
发文量
0
审稿时长
38 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信